143 related articles for article (PubMed ID: 32902157)
21. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
[TBL] [Abstract][Full Text] [Related]
22. Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells.
Separovic D; Breen P; Joseph N; Bielawski J; Pierce JS; VAN Buren E; Gudz TI
Anticancer Res; 2012 Mar; 32(3):753-60. PubMed ID: 22399588
[TBL] [Abstract][Full Text] [Related]
23. Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis.
Scheffel MJ; Helke K; Lu P; Bowers JS; Ogretmen B; Garrett-Mayer E; Paulos CM; Voelkel-Johnson C
Sci Rep; 2017 Nov; 7(1):15552. PubMed ID: 29138469
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
25. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
[TBL] [Abstract][Full Text] [Related]
26. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
30. CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity.
Hammerschmidt P; Ostkotte D; Nolte H; Gerl MJ; Jais A; Brunner HL; Sprenger HG; Awazawa M; Nicholls HT; Turpin-Nolan SM; Langer T; Krüger M; Brügger B; Brüning JC
Cell; 2019 May; 177(6):1536-1552.e23. PubMed ID: 31150623
[TBL] [Abstract][Full Text] [Related]
31. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities.
Ebel P; Vom Dorp K; Petrasch-Parwez E; Zlomuzica A; Kinugawa K; Mariani J; Minich D; Ginkel C; Welcker J; Degen J; Eckhardt M; Dere E; Dörmann P; Willecke K
J Biol Chem; 2013 Jul; 288(29):21433-21447. PubMed ID: 23760501
[TBL] [Abstract][Full Text] [Related]
34. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts.
Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI
Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294
[TBL] [Abstract][Full Text] [Related]
35. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide.
Schiffmann S; Ziebell S; Sandner J; Birod K; Deckmann K; Hartmann D; Rode S; Schmidt H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2010 Dec; 80(11):1632-40. PubMed ID: 20735991
[TBL] [Abstract][Full Text] [Related]
36. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J
Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
38. TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis.
Gencer S; Oleinik N; Kim J; Panneer Selvam S; De Palma R; Dany M; Nganga R; Thomas RJ; Senkal CE; Howe PH; Ogretmen B
Sci Signal; 2017 Oct; 10(502):. PubMed ID: 29066540
[TBL] [Abstract][Full Text] [Related]
39. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity.
Gu D; Jin H; Jin G; Wang C; Wang N; Hu F; Luo Q; Chu W; Yao M; Qin W
Cancer Lett; 2016 Aug; 379(1):107-16. PubMed ID: 27241665
[TBL] [Abstract][Full Text] [Related]
40. C16‑ceramide and sphingosine 1‑phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
Kim MH; Park JW; Lee EJ; Kim S; Shin SH; Ahn JH; Jung Y; Park I; Park WJ
Oncol Rep; 2018 Nov; 40(5):2977-2987. PubMed ID: 30226616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
